From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

LGBTIQA+ Cancer Care Education Series

Delivery mode
Live Online
CPD Hours
Up to 8
Cost
FREE
Multiple dates, 6 Oct 2026 - 1 Jun 2027, 6:30pm AEDT
Online (National)

Overview

Cancer outcomes are not only shaped by clinical care, but by whether people feel safe, respected, and included throughout their healthcare journey.   

The LGBTIQA+ Cancer Care Education Series is an eight-part webinar series designed to strengthen healthcare professionals’ ability to provide inclusive, affirming, and person-centred cancer care for LGBTIQA+ communities. 

Across the series, participants will explore the unique experiences, challenges, and healthcare needs of LGBTIQA+ people throughout the cancer journey – from prevention and early detection to diagnosis, treatment, survivorship, and supportive care. 

Led by expert clinicians, researchers, and community representatives, each session combines the latest evidence with practical guidance for improving equity in cancer care and supporting the implementation of the Optimal Care Pathway for LGBTIQA+ People with Cancer in clinical practice. 

All sessions are hosted live on zoom and are recorded for later viewing.

Click here to view the downloadable flyer for this series!

2026 Series Schedule

Platform: Live Online – Zoom

Time:

  • Until 2 March Session: 6:30pm – 7:30pm AEDT
  • After 2 March Session: 6:30pm – 7:30pm AEST

Cancer in LGBTIQA+ Communities: Epidemiology, Prevention and Early Detection

| 6 October 2026

| Scott Walsberger
  Dr Leigh Barlow
  Dr Megan Smith

| Supported by Gilead

Diagnosis and Treatment: Delivering Trauma-Informed, Inclusive Cancer Care

| 3 November 2026

 | Bec Cerio
   Dr Trevor Tejada-Berges
   Prof Rosalie Power
   Son Vivienne

| Supported by Gilead

Cancer, Sexuality and Intimacy

| 1 December 2026

| Prof. Jane Ussher
  Dr Daniel Brown
  Melissa Hadley Barrett
  Prof Graham Brown

| Supported by Gilead

Gender, Cancer and Affirming Care

2 February 2027

| Prof. Jane Ussher
  Prof. Ada Cheung
  Aurora Green

| Supported by Gilead

Cancer Care for People with Innate Variations of Sex Characteristics

2 March 2027

| Prof. Jane Ussher
  Prof. Morgan Carpenter

| Supported by Gilead

Partners, Carers and Chosen Family

13 April 2027

| Kevin Bloom
  Richelle Menzies

| Supported by Gilead

Survivorship and Living Well After Cancer

4 May 2027

| Dr Nicholas Hart
  Dr Darren Haywood
  Dimitri Daskalakis
  Aurora Green

| Supported by Gilead

Palliative and End-of-Life Care for LGBTIQA+ People

1 June 2027

| Prof. David Currow
  Dr Gareth Watts
  Rob Lake

| Supported by Gilead

Target Audience:

The LGBTQIA+ Cancer Optimal Care Pathway Education Series is intended for anyone involved in supporting, caring for, or improving health outcomes for LGBTQIA+ people affected by cancer. This includes, but is not limited to:

    • Healthcare professionals involved in cancer care, including oncologists, nurses, allied health professionals, general practitioners and other clinical staff

    • Sexual health and LGBTQIA+ health clinicians

    • Researchers and academics working in cancer, LGBTQIA+ health, sexual health or related fields

    • Community members, LGBTQIA+ community representatives and advocates

    • People with lived experience of cancer, including survivors, partners, families and carers

    • Health and community service providers interested in improving inclusive and equitable cancer care

Learning Outcomes:

On completion of this course and its components, participants will be able to:

    • Describe the experiences, needs and priorities of LGBTIQA+ people affected by cancer across the cancer care continuum.

    • Understand the impact of stigma, discrimination, healthcare barriers on cancer experiences and outcomes for LGBTIQA+ communities.

    • Explore the intersections between cancer, sexuality, gender identity, sex characteristics, relationships, chosen family and wellbeing.

    • Identify opportunities to improve cancer care and support for LGBTIQA+ people through evidence-informed practice, community engagement and the application of the LGBTIQA+ Cancer Optimal Care Pathway.

Endorsement:

Endorsement is currently pending. This activity may be suitable for self-claiming CPD hours with your professional body. An estimated equivalent of 1 CPD hours per session applies.

Funding:

This Cancer Patient Support Program received grant funding from the Australian Government. 

For more information:

Please contact ASHM Education at [email protected] or call 0431 320 429.

Upcoming Conferences and Events

APSAD 2026

8 - 11 Nov 2026
Esplanade Hotel Fremantle by Rydges, Walyalup (WA, Australia)
Sector Event

The AAAH Youth Health Conference 2027

5 - 7 May 2027
Qt Hotel Gold Coast on Yugambeh Country (QLD, Australia)

17th Australasian Viral Hepatitis Conference

18 - 20 Aug 2027
Novotel Wollongong Northbeach, Dharawal (Wollongong) (NSW, Australia)